Literature DB >> 22066947

Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension.

Sharilyn Almodovar1, Rob Knight, Amanda A Allshouse, Sarah Roemer, Catherine Lozupone, Daniel McDonald, Jeremy Widmann, Norbert F Voelkel, Robert J Shelton, Edu B Suarez, Kenneth W Hammer, Cecile Goujard, Nicola Petrosillo, Gerald Simonneau, Priscilla Y Hsue, Marc Humbert, Sonia C Flores.   

Abstract

Severe pulmonary hypertension (PH) associated with vascular remodeling is a long-term complication of HIV infection (HIV-PH) affecting 1/200 infected individuals vs. 1/200,000 frequency in the uninfected population. Factors accounting for increased PH susceptibility in HIV-infected individuals are unknown. Rhesus macaques infected with chimeric SHIVnef virions but not with SIV display PH-like pulmonary vascular remodeling suggesting that HIV-Nef is associated with PH; these monkeys showed changes in nef sequences that correlated with pathogenesis after passage in vivo. We further examined whether HIV-nef alleles in HIV-PH subjects have signature sequences associated with the disease phenotype. We evaluated specimens from participants with and without HIV-PH from European Registries and validated results with samples collected as part of the Lung-HIV Studies in San Francisco. We found that 10 polymorphisms in nef were overrepresented in blood cells or lung tissue specimens from European HIV-PH individuals but significantly less frequent in HIV-infected individuals without PH. These polymorphisms mapped to known functional domains in Nef. In the validation cohort, 7/10 polymorphisms in the HIV-nef gene were confirmed; these polymorphisms arose independently from viral load, CD4(+) T cell counts, length of infection, and antiretroviral therapy status. Two out of 10 polymorphisms were previously reported in macaques with PH-like pulmonary vascular remodeling. Cloned recombinant Nef proteins from clinical samples down-regulated CD4, suggesting that these primary isolates are functional. This study offers new insights into the association between Nef polymorphisms in functional domains and the HIV-PH phenotype. The utility of these polymorphisms as predictors of PH should be examined in a larger population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22066947      PMCID: PMC3358101          DOI: 10.1089/AID.2011.0021

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  41 in total

1.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

2.  Pulmonary hypertension in individuals with HIV infection.

Authors:  Nicola Petrosillo; Pierangelo Chinello; Stefania Cicalini
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

3.  HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.

Authors:  John C Marecki; Carlyne D Cool; Jane E Parr; Virginia E Beckey; Paul A Luciw; Alice F Tarantal; Angela Carville; Richard P Shannon; Adela Cota-Gomez; Rubin M Tuder; Norbert F Voelkel; Sonia C Flores
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

4.  A USA-based registry for pulmonary arterial hypertension: 1982-2006.

Authors:  T Thenappan; S J Shah; S Rich; M Gomberg-Maitland
Journal:  Eur Respir J       Date:  2007-09-05       Impact factor: 16.671

Review 5.  The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors.

Authors:  V Piguet; O Schwartz; S Le Gall; D Trono
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

Review 6.  Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.

Authors:  Mpiko Ntsekhe; James Hakim
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

7.  Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: compartmentalized regulation of SIV.

Authors:  Sheila A Barber; Lucio Gama; Ming Li; Tauni Voelker; John E Anderson; M Christine Zink; Patrick M Tarwater; Lucy M Carruth; Janice E Clements
Journal:  J Infect Dis       Date:  2006-08-29       Impact factor: 5.226

8.  The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR.

Authors:  S Grzesiek; S J Stahl; P T Wingfield; A Bax
Journal:  Biochemistry       Date:  1996-08-13       Impact factor: 3.162

9.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

10.  HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail.

Authors:  Jeremiah F Roeth; Maya Williams; Matthew R Kasper; Tracey M Filzen; Kathleen L Collins
Journal:  J Cell Biol       Date:  2004-11-29       Impact factor: 10.539

View more
  22 in total

1.  HIV-1 Nef promotes cell proliferation and microRNA dysregulation in lung cells.

Authors:  Maryline Santerre; Wissam Chatila; Ying Wang; Ruma Mukerjee; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2019-01-06       Impact factor: 4.534

Review 2.  Cardiovascular Complications of HIV in Endemic Countries.

Authors:  Matthew J Feinstein; Milana Bogorodskaya; Gerald S Bloomfield; Rajesh Vedanthan; Mark J Siedner; Gene F Kwan; Christopher T Longenecker
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

3.  Pulmonary research in 2013 and beyond: a National Heart, Lung, and Blood Institute perspective.

Authors:  James P Kiley; Robert M Senior
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-09-07       Impact factor: 5.464

Review 4.  The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.

Authors:  Sharilyn Almodovar
Journal:  Viral Immunol       Date:  2014-05-05       Impact factor: 2.257

5.  Lung Vascular Remodeling, Cardiac Hypertrophy, and Inflammatory Cytokines in SHIVnef-Infected Macaques.

Authors:  Sharilyn Almodovar; Jessica Swanson; Luis D Giavedoni; Sreetharan Kanthaswamy; Carlin S Long; Norbert F Voelkel; Michael G Edwards; Joy M Folkvord; Elizabeth Connick; Susan V Westmoreland; Paul A Luciw; Sonia C Flores
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

6.  Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.

Authors:  Rohit B Sangal; Lynn E Taylor; Fizza Gillani; Athena Poppas; James R Klinger; Corey E Ventetuolo
Journal:  Ann Am Thorac Soc       Date:  2014-12

Review 7.  Heart-lung interaction via infection.

Authors:  Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 8.  Pathogenesis of HIV and the lung.

Authors:  Matthew R Gingo; Alison Morris
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

Review 9.  Human immunodeficiency virus-associated pulmonary arterial hypertension.

Authors:  Christopher F Barnett; Priscilla Y Hsue
Journal:  Clin Chest Med       Date:  2013-04-08       Impact factor: 2.878

Review 10.  Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.

Authors:  Ting Wang; Ru Yi; Linden Ann Green; Sarvesh Chelvanambi; Michael Seimetz; Matthias Clauss
Journal:  Cardiovasc Pathol       Date:  2015-07-09       Impact factor: 2.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.